61 related articles for article (PubMed ID: 26514466)
1. Cervical Cancer Screening in an Early Diagnosis and Screening Center in Mersin, Turkey.
Nayir T; Okyay RA; Nazlican E; Yesilyurt H; Akbaba M; Ilhan B; Kemik A
Asian Pac J Cancer Prev; 2015; 16(16):6909-12. PubMed ID: 26514466
[TBL] [Abstract][Full Text] [Related]
2. A Study of Pap Smears in HIV-Positive and HIV-Negative Women from a Tertiary Care Center in South India.
Gupta K; Philipose CS; Rai S; Ramapuram J; Kaur G; Kini H; Gv C; Adiga D
Acta Cytol; 2019; 63(1):50-55. PubMed ID: 30721904
[TBL] [Abstract][Full Text] [Related]
3. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
[TBL] [Abstract][Full Text] [Related]
4. Detection of abnormal cervical cytology in papanicolaou smears in a tertiary care center.
Hirachand S; Bajracharya J; Pradhanang S; Lama S
JNMA J Nepal Med Assoc; 2013; 52(191):462-5. PubMed ID: 24907951
[TBL] [Abstract][Full Text] [Related]
5. Age Specific Cytological Abnormalities in Women Screened for Cervical Cancer in the Emirate of Abu Dhabi.
Al Zaabi M; Al Muqbali S; Al Sayadi T; Al Ameeri S; Coetsee K; Balayah Z; Ortashi O
Asian Pac J Cancer Prev; 2015; 16(15):6375-9. PubMed ID: 26434845
[TBL] [Abstract][Full Text] [Related]
6. Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV.
Massad LS; Xie X; Minkoff HL; Michel KG; D'Souza G; Wang CC; Konkle-Parker D; Ofotokun I; Fischl MA; Rahangdale L; Strickler HD
Am J Obstet Gynecol; 2021 Oct; 225(4):411.e1-411.e7. PubMed ID: 33957115
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pre-malignant cervical lesions in females presenting with abnormal pelvic complaints.
Tahir QA; Bukhari MH
J Pak Med Assoc; 2020 Feb; 70(2):272-275. PubMed ID: 32063620
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the LC-1000 Flow Cytometry Screening System for Cervical Cancer Screening in Routine Health Checkups.
Heo I; Kwak HJ; Nah EH; Cho S; Kim S; Cho HI
Acta Cytol; 2018; 62(4):279-287. PubMed ID: 29843120
[TBL] [Abstract][Full Text] [Related]
11. Results of Cervical Cancer Screening in the Rural Population of Lucknow West, India, through a Camp Approach.
Misra JS; Srivastava AN; Gupta HP
Acta Cytol; 2018; 62(4):273-278. PubMed ID: 29898440
[TBL] [Abstract][Full Text] [Related]
12. Cervical Cancer Screening Services at Tertiary Healthcare Facility: An Alternative Approach.
Dhanasekaran K; Verma C; Kumar V; Hariprasad R; Gupta R; Gupta S; Mehrotra R
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1265-1269. PubMed ID: 31030504
[TBL] [Abstract][Full Text] [Related]
13. Variations in Progression and Regression of Precancerous Lesions of the Uterine Cervix on Cytology Testing Among Women of Different Races.
Martingano D; Renson A; Martingano AJ; Martingano FX
J Am Osteopath Assoc; 2018 Jan; 118(1):8-18. PubMed ID: 29309102
[TBL] [Abstract][Full Text] [Related]
14. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening in Turkey: a community-based experience after 60 years of pap smear usage.
Demirhindi H; Nazlican E; Akbaba M
Asian Pac J Cancer Prev; 2012; 13(12):6497-500. PubMed ID: 23464481
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Abnormal Papanicolaou Test Results and Related Factors among Women Living in Zanjan, Iran.
Maleki A; Ahmadnia E; Avazeh A; Mazloomzadeh S; Molaei B; Jalilvand A
Asian Pac J Cancer Prev; 2015; 16(16):6935-9. PubMed ID: 26514471
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic follow-up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital.
Tao X; Austin RM; Zhang H; Zhang L; Xiao J; Zhou X; Wang L; Zhao C
Cancer Cytopathol; 2017 Dec; 125(12):947-953. PubMed ID: 28885778
[TBL] [Abstract][Full Text] [Related]
18. Impact of Patient-Directed Cytology Results Correspondence Program on Follow-Up of High-Grade Pap Tests.
Tavasoli SM; Kane E; Kupets R
J Obstet Gynaecol Can; 2019 Oct; 41(10):1461-1469. PubMed ID: 31053566
[TBL] [Abstract][Full Text] [Related]
19. [Relation of cervical cancer with the results of human papillomavirus (HPV) screening carried out via hybrid capture 2 method on 52.000 women in Erzurum].
Göktuğ Kadıoğlu B; Çınar Tanrıverdi E; Alay H; Uçar M
Mikrobiyol Bul; 2018 Oct; 52(4):367-375. PubMed ID: 30522422
[TBL] [Abstract][Full Text] [Related]
20. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
